诊断病理学：开放获取

抽象的

Multi-Drug Therapy Including Immune Checkpoint Inhibitors in Ovarian Cancer

Hitomi Yamashita, Kentaro Nakayama and Satoru Kyo

Ovarian cancer has the worst prognosis among gynecological cancers. Since only a few cases of ovarian cancer could be treated effectively with immune checkpoint inhibitor monotherapy, to improve the prognosis of ovarian cancer, multi-drug therapy including immune checkpoint inhibitors is necessary. In this short commentary, we highlight the need for studies on novel treatment strategies.